Publication | Closed Access
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
246
Citations
20
References
2012
Year
Metronomic TherapyPharmacologyClinical EvidencePharmacotherapyAnti-cancer AgentAntitumour ActivityMedicineCyp17a1 Inhibitor AbirateroneDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1